Global fund region | Median costs (number of purchases) (inter-quartile ranges) for the 2005–2012 period | ||
---|---|---|---|
LLINs | Malaria test kits | AL anti-malarial | |
East Asia/Pacific | 4.3 (92) (3.9-5.2) | 0.63 (59) (0.55-0.76) | 0.07 (115) (0.06-0.07) |
Eastern Europe/Central Asia | 6.1 (19) (5.5-7.1) | 0.80 (1) (0.80-0.80) | 0.08 (5) (0.06-0.08) |
Latin America/Caribbean | 5.2 (32) (4.0-6.0) | 1.1 (29) (0.82-1.6) | 0.08 (20) (0.06-0.09) |
North Africa/Middle East | 4.8 (59) (3.5-6.1) | 0.64 (22) (0.56-0.81) | 0.07 (24) (0.06-0.07) |
South Asia | 5.2 (59) (4.6-5.7) | 0.61 (59) (0.32-0.83) | 0.06 (27) (0.06-0.08) |
SSA: East Africa | 6.0 (95) (4.8-7.8) | 0.87 (72) (0.56-1.1) | 0.06 (206) (0.06-0.07) |
SSA: Southern Africa | 5.5 (20) (5.1-6.2) | 0.68 (23) (0.55-0.77) | 0.06 (81) (0.06-0.07) |
SSA: West and Central Africa | 5.5 (80) (4.5-6.6) | 0.57 (57) (0.46-0.97) | 0.06 (142) (0.06-0.07) |
p- Value (Kruskal-Wallis Test) | p < 0.001 | p < 0.001 | p = 0.001 |